Eli Lilly’s intranasal formulation of glucagon – called Baqsimi – is the first alternative to injectable glucagon for severe hypoglycaemia, which typically occurs when people with diabetes ...
The EMA’s human medicines advisory committee has recommended approval of Eli Lilly’s Baqsimi ... Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback